Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
5,075.00    -515.00 (-9.21%)
Bid:
5,060.00
Ask:
5,065.00
Spread: 5.00 (0.099%)
Market Cap: $1.33t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

Shareholder Return Program for FY2018-2020

31 Oct 2017 07:00

RNS Number : 0625V
Samsung Electronics Co. Ld
31 October 2017
 

Shareholder Return Program for FY2018-2020

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) ("SEC") announced today that its Board of Directors at their meeting on October 31, 2017 approved a shareholder return program for FY2018-2020. The core strategy of the policy enhancement is to provide investor community with greater predictability on the returns program.

· The company will increase annual dividends for FY2017 by 20 percent compared to that of FY2016, which will be followed by a 100 percent rise in dividends for FY2018 compared to that of FY2017. The FY2019 and FY2020 dividends will be kept at the same level with that of FY2018.

· Future M&A investments will not be deducted from free cash flow (FCF). This policy change will prevent the amount of capital available to return to shareholders from decreasing and result in greater transparency and predictability.

· The company will change the standard period of returning minimum 50% of FCF from a one-year basis to a three-year basis. This is to address steep fluctuation of annual shareholder return resulting from fluctuation of the annual FCF. After dividend payouts, any remaining portion of the 50% of FCF available for shareholder returns will be used either for additional cash dividends or share buybacks as deemed appropriate.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUAOURBNARORA
Date   Source Headline
31st Oct 20249:02 amRNSDelisting and Listing of Stocks
31st Oct 20247:00 amRNSQuarterly Dividend for Third Quarter 2024
31st Oct 20247:00 amRNS2024 3Q Earnings Release
31st Oct 20247:00 amRNSAnnouncement of Capex Plan for FY2024
8th Oct 20247:00 amRNSNotice of 3Q 2024 Earning Release
8th Oct 20247:00 amRNS3Q 2024 Pre-Earnings Guidance
30th Aug 202410:52 amRNS2024 Half-year Business Report
31st Jul 20249:33 amRNSTransaction with Affiliate Company
31st Jul 20249:26 amRNSCharitable Contribution
31st Jul 20247:00 amRNSQuarterly Dividend for Second Quarter 2024
31st Jul 20247:00 amRNS2024 2Q Earnings Release
5th Jul 20247:55 amRNSNotice of 2Q 2024 Earnings Release Schedule
5th Jul 20247:45 amRNS2Q 2024 Pre-Earnings Guidance
28th Jun 20248:53 amRNSSustainability Report 2024
31st May 202410:23 amRNSCorporate Governance Report FY2023
31st May 20247:00 amRNS2024 1Q INTERIM BUSINESS REPORT
21st May 20249:34 amRNSNotice on Change of CEO
30th Apr 20248:10 amRNSTransactions with Affiliated Companies
30th Apr 20247:00 amRNSQuarterly Dividend for First Quarter 2024
30th Apr 20247:00 amRNS2024 1Q Earnings Release
30th Apr 20247:00 amRNS2023 Business Report
5th Apr 20247:11 amRNSNotice of 1Q 2024 Earnings Release Schedule
5th Apr 20247:00 amRNS1Q 2024 Pre-Earnings Guidance
20th Mar 20249:07 amRNSTransactions with Affiliated Companies
20th Mar 20249:05 amRNSResults of the 55th Annual General Meeting
21st Feb 20247:00 amRNSReference Material for 2024 AGM
20th Feb 20248:31 amRNSCharitable Contribution
19th Feb 20249:40 amRNS2023 Separate Financial Statements
19th Feb 20249:34 amRNS2023 Consolidated Financial Statements
31st Jan 20247:00 amRNSYear-End Dividend for FY2023
31st Jan 20247:00 amRNS2023 4Q Earning Release
31st Jan 20247:00 amRNSTransactions with Affiliated Companies
31st Jan 20247:00 amRNSShareholder Return Program for FY2024-2026
31st Jan 20247:00 amRNSAnnouncement of Capex Result for FY2023
9th Jan 20247:00 amRNSNotice of 4Q 2023 Earning Release
9th Jan 20247:00 amRNS4Q 2023 Pre-Earnings Guidance
1st Dec 202311:09 amRNSCharitable Contribution
30th Nov 20237:54 amRNSTransactions with Affiliated Companies
30th Nov 20237:34 amRNS2023 3Q Interim Business Report
6th Nov 20238:43 amRNSAnnouncement of Investor Relations Event
31st Oct 20237:21 amRNSTransactions with Affiliated Companies
31st Oct 20237:18 amRNSAnnouncement of Capex Plan for FY2023
31st Oct 20237:13 amRNSQuarterly Dividend for Third Quarter 2023
31st Oct 20237:10 amRNS2023 3Q Earning Release
11th Oct 20237:10 amRNSNotice of 3Q 2023 Earning Release
11th Oct 20237:04 amRNS3Q 2023 Pre-Earnings Guidance
21st Sep 20237:30 amRNS2022 Business Report
21st Sep 20237:29 amRNS2022 Separate Financial Statements
21st Sep 20237:29 amRNS2022 Consolidated Financial Statements
31st Aug 20238:15 amRNS2023 Half-year Business Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.